November 26, 2018

Dr. Dougan was featured in an article, since she is a recipient of a research grant from Pancreatic Cancer Action Network (PanCAN). Read the story.

September, 2018

Drs. Aguirre, Hahn and Wolpin published a study in Cancer Discovery that reported on real-time genomic characterization of advanced pancreatic cancer to enable precision medicine. (Aguirre AJ, et al. Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. Cancer Discov. 2018;8(9):1096-111. Epub 2018/06/16. doi: 10.1158/2159-8290.CD-18-0275. PubMed PMID: 29903880.).


March 8, 2018

This year’s “Saving by Shaving” flagship event organized by Granite Telecommunications raised 6.5 million dollars for Dana-Farber cancer research. Granite staff along with local celebrities and government officials shaved their heads in a show of solidarity for patients undergoing cancer treatment. In return, the Hale family made a gift to Dana-Farber on behalf of each person who took a turn in the barber’s chair. Read more coverage. 


March 8, 2018
Drs. Wolpin, Hahn, and Aguirre published a study in JAMA Oncol that reported on the survival from pancreatic cancer with different genetic alterations (Qian ZR, et al., Association of Alterations in Main Driver Genes with Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2017).

January 15, 2018
Dr. Wolpin receives news that his Lustgarten grant has been selected for funding.


June 1, 2017
Dr. Wolpin published a study in J Clin Oncol demonstrating that cigarette smoking is associated with reduced survival from pancreatic cancer (Yuan C, et al., Cigarette Smoking and Pancreatic Cancer Survival. J Clin Oncol. 2017;35(16):1822-8.).

June 29, 2017
Drs. Hahn, Aguirre, and Dougan receive news that their grant application on pancreatic ductal adenocarcinoma and the tumor microenvironment has been funded by the NIH (U01 CA224146-01).

May 15, 2017
Dr. Wolpin is appointed as the new Director of the Gastrointestinal Cancer Center.

February 7, 2017
Drs. Hahn and Aguirre published in Cell Rep that the ATXN1L-CIC-ETS transcription factor axis modulates sensitivity to MAPK pathway inhibition (Wang B, et al., ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition. Cell Rep. 2017;18(6):1543-57.).

February 21, 2017
Dr. Wolpin is appointed as the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute.

Comments are closed.